Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium

Shock

Volumn 5, Issue 1, 1996, Pages 66-71

  Haessler, Reinhard ^a,d   Davis, Richard F ^a,b   Wolff, Roger A ^a   Kuzume, Koh ^c   Shangraw, Robert ^a   Van Winkle, Donna M ^a,b,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c EHIME UNIVERSITY   (Japan)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID; LACTIC ACID; PYRUVATE DEHYDROGENASE COMPLEX;

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMODYNAMICS; METABOLISM; PATHOLOGY; RABBIT; REPERFUSION INJURY;

ANIMALS; BLOOD GLUCOSE; DICHLOROACETATE; ENZYME ACTIVATION; HEMODYNAMIC PROCESSES; LACTIC ACID; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PYRUVATE DEHYDROGENASE COMPLEX; RABBITS;

EID: 0029684002     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199601000-00013     Document Type: Article

References (21)

1. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 38: 1124-1144, 1989.
2. Kamel KS, Cheema-Dhadli S, Halperin ML: Is accelerated oxidation of lactate required for dichloroacetate to lower the level of lactate in blood? Can J Physiol Pharmacol 70:1477-1482, 1992.
3. Stacpoole PW, Wright EC, Baumgartner TG, et al: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults: The dichloroacetate-lactic acidosis study group. New Engl J Med 327:1564-1569, 1992.
4. Chang LH, Shimizu H, Abiko H, et al: Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats. J Cereb Blood Flow Metab 12:1030-1038, 1992.
5. Dimlich RV, Nielsen MM: Facilitating postischemic reduction of cerebral lactate in rats. Stroke 23:1145-1152, 1992.
6. Mizushima M: Effects of dichloroacetate in the ischemic heart: Analysis of hemodynamics, myocardial energy metabolism and myocardial pH. Hokkaido Igaku Zasshi 65:298-310, 1990.
7. Sakai K, Ichihara K, Nasa Y, Kamigaki M, Abiko Y: Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs. Arch Int Pharmacodyn Ther 307:92-108, 1990.
8. McVeigh JJ, Lopaschuk GD: Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259: H1079-HI085, 1990.
9. Racey-Burns LA, Burns AH, Summer WR, Shepherd RE: The effect of dichloroacetate on the isolated no flow arrested rat heart. Life Sci 44:2015-2023, 1989.
10. Lopaschuk GD, Wambolt RB, Barr RL: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264:135-144, 1993.
11. Curry SH, Chu P-I, Baumgartner TG, Stacpoole PW: Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther 37:89-93, 1985.
12. Mjos OD, Miller NE, Riemersma RA, Oliver MF: Effects of dichloroacetate on myocardial substrate extraction, epicardial ST-segment elevation, and ventricular blood flow following coronary occlusion in dogs. Cardiovasc Res 10:427-436, 1976.
13. Reimer KA, Jennings RB: The "wavefront phenomenon" of myocardial ischemic death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633-644, 1979.
14. Fishbein MC, Meerbaum S, Rit J, et al: Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101:593-600, 1981.
15. Lukas G, Vyas KH, Brindle SD, Le Sher AR, Wagner WE Jr: Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration. J Pharmacol Sci 69:419-421, 1980.
16. Wells PG, Moore GW, Rabin D, Wildinson GR, Oates JA, Stacpoole PW: Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia 19:109-113, 1980.
17. Constantin-Teodosiu D, Cederblad G, Hultman E: A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem 198:347-351, 1991.
18. Miura T, Downey JM, Ooiwa H, et al: Progression of myocardial infarction in a collateral flow-deficient species. Jpn Heart J 30:695-708, 1989.
19. Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol 36:938-953, 1975.
20. Lopaschuk GD, Spafford M, Davies NJ, Wall SR: Glucose and palmitate oxidation in isolated working rat hearts reperfused following a period of transient global ischemia. Circ Res 66:546-553, 1990.
21. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal injury in ischemic myocardium. Circulation 74:1124-1136, 1986.